Day in the life of a consultant at Inbeeo From dynamic meetings to deep strategic work in a wide Read More »
Communicate the value How a critical assessment of company narratives helped to refine the strategy for a high-cost innovative therapy launch in oncology Read More
Navigate access policies How knowledge management and a roadmap with clear and detailed process descriptions enable global brand teams to prepare for the EU JCA Read More
Define Your Value Strategy How a comprehensive catalogue of early and alternative access pathways facilitated accelerated access for patients with rare diseases Read More
Optimize your evidence plan How an early payer value narrative informed the evidence generation plan for an innovative therapy targeting a metabolic disease Read More
Define Your Value Strategy How assessing the pricing and reimbursement risks associated with a product withdrawal supported the action steps to take in key Central and Eastern EU markets Read More
Define Your Value Strategy How a deep-dive analysis of pricing methodologies and access routes in Australia allowed early planning of market access strategies for orphan drugs Read More
Price Your Asset Right How leveraging a ‘glocal’ approach supported the assessment of the pricing and reimbursement potential of a breakthrough orphan drug in China Read More
Optimize your evidence plan How a deep understanding of CDx pricing and reimbursement informed strategic R&D decision-making Read More
Navigate access policies How crafting a versatile value narrative empowered a pharmaceutical client to successfully communicate the value of their digital ecosystem Read More
Navigate access policies How secondary research, company workshops and policymaker engagement allowed for elevating the response to cost containment in Europe Read More
Optimize your evidence plan How creating a unified vision and comprehensive framework for Real-World Evidence (RWE) supported seamless execution of RWE projects Read More
Communicate the value How engaging with affiliates enabled the development of a fully adaptable budget impact model to support successful launches across all Wave 1 markets Read More
Define Your Value Strategy How partnering with local experts helped define third wave launch countries for our client’s geographical expansion Read More
Navigate access policies How developing a framework for Value Based Partnerships provided a platform for affiliates to explore how different tactics could be used to accelerate access Read More
Navigate access policies How expert insights have helped gain a better understanding on the upcoming Joint Clinical Assessment in the EU and its challenges Read More
Communicate the value How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders Read More
Price Your Asset Right How a semi-quantitative assessment of achievable pricing, combined with extensive input from global & affiliate colleagues, enabled the refinement of a global pricing strategy leading up to launch Read More
Price Your Asset Right How an innovative pricing calculator enabled the identification of key value drivers and compelling value metrics to support a pricing strategy Read More
Price Your Asset Right How a deep understanding of pricing mechanisms in Japan enabled the formulation of a robust price estimate for a novel radiopharmaceutical Read More
Price Your Asset Right How developing an early payer value story and value messages supported a differentiated offer within neurology, covering multiple possible scenarios at global and regional levels Read More
Define Your Value Strategy How i-vbp® enabled the identification of the disease attractiveness and key value metrics to support a product’s indication prioritization strategy Read More
Define Your Value Strategy How a thorough analysis of potential access scenarios allowed the successful launch of a new product indication Read More
Optimize your evidence plan How developing and testing of a value narrative with payers formed the foundation for a strong early market access strategy Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the clinical development plan and market access strategy for a novel drug in PD Read More
Define Your Value Strategy How i-vbp® helped a specialty company pilot a new way of assessing the value of acquisition targets in multiple rare CNS diseases Read More
Price Your Asset Right How the development of an international reference pricing model, supported by a deep understanding of market access dynamics, has supported launch sequencing of two specialty products Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies Read More
Communicate the value How focusing on the operational elements of pricing strategy supported in-country teams to strengthen their approach to pricing incremental innovation Read More
Communicate the value How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product Read More
Price Your Asset Right How a deep-dive analysis of key analogues facilitated the development of focused recommendations to optimize long-term success for an advanced oncology product facing multiple indication expansions Read More
